InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
15
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Chopas James George, VP/Chief Accounting Officer. Officer active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 30 filings have been published. Split: 0 buy · 15 sells. Total volume traded: €289k. History available since 30 August 2021. The latest transaction was filed on 28 January 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Chopas James George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
65,955 sharesCommon StockSEC:0001193125-26-224627:0
16,150 shares0Common StockSEC:0001492422-26-000078:0
2,064 shares@ US$21.765410.3% of flowCommon StockSEC:0001492422-26-000060:0
726 shares@ US$19.79293.3% of flowCommon StockSEC:0001492422-26-000044:0
873 shares@ US$22.18724.4% of flowCommon StockSEC:0001492422-26-000031:0
189 shares@ US$24.1921.3% of flowCommon StockSEC:0001492422-25-000005:0
548 shares@ US$28.0774.4% of flowCommon StockSEC:0001127602-25-021110:0
6,250 shares0Common StockSEC:0001127602-25-017836:0
183 shares@ US$24.82371.4% of flowCommon StockSEC:0001127602-25-009738:0
1,096 shares@ US$30.425511.1% of flowCommon StockSEC:0001127602-25-001829:0
715 shares@ US$29.95827.2% of flowCommon StockSEC:0001127602-25-001614:0
12,591 shares0Common StockSEC:0001127602-25-001614:1
783 shares@ US$28.70217.6% of flowCommon StockSEC:0001127602-25-001184:0
192 shares@ US$36.2062.2% of flowCommon StockSEC:0001127602-24-024074:0
550 shares@ US$39.4916.8% of flowCommon StockSEC:0001127602-24-023392:0
184 shares@ US$56.4613.3% of flowCommon StockSEC:0001127602-24-010416:0
1,061 shares@ US$64.99621.9% of flowCommon StockSEC:0001127602-24-001928:0
8,312 shares0Common StockSEC:0001127602-24-001441:0
132 shares@ US$46.03622.0% of flowCommon StockSEC:0001127602-23-026188:0
2,500 shares0Common StockSEC:0001127602-23-024308:0
551 shares@ US$41.2267.2% of flowCommon StockSEC:0001127602-23-023568:0
4,044 shares0Common StockSEC:0000899243-23-005785:0
919 shares@ US$52.0515.3% of flowCommon StockSEC:0001127602-23-002111:0
9,621 shares0Common StockSEC:0001127602-23-001491:0
130 shares@ US$58.002.7% of flowCommon StockSEC:0001127602-22-024299:0
25 of 30 declarations
About Chopas James George
Chopas James George is VP/Chief Accounting Officer at Apellis Pharmaceuticals, Inc. He has 30 filings in total, and in the sampled recent filings from 2021-09-01 to 2026-05-14, sales total 288897 EUR, with the modal transaction nature listed as sale.
